451 related articles for article (PubMed ID: 16537455)
81. Transient Receptor Potential Ankyrin 1 Channel Involved in Atherosclerosis and Macrophage-Foam Cell Formation.
Zhao JF; Shyue SK; Kou YR; Lu TM; Lee TS
Int J Biol Sci; 2016; 12(7):812-23. PubMed ID: 27313495
[TBL] [Abstract][Full Text] [Related]
82. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice.
Bujold K; Mellal K; Zoccal KF; Rhainds D; Brissette L; Febbraio M; Marleau S; Ong H
Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196
[TBL] [Abstract][Full Text] [Related]
83. Homocysteine accelerates atherosclerosis via inhibiting LXRα-mediated ABCA1/ABCG1-dependent cholesterol efflux from macrophages.
Jin P; Bian Y; Wang K; Cong G; Yan R; Sha Y; Ma X; Zhou J; Yuan Z; Jia S
Life Sci; 2018 Dec; 214():41-50. PubMed ID: 30393020
[TBL] [Abstract][Full Text] [Related]
84. Renal dysfunction potentiates foam cell formation by repressing ABCA1.
Zuo Y; Yancey P; Castro I; Khan WN; Motojima M; Ichikawa I; Fogo AB; Linton MF; Fazio S; Kon V
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1277-82. PubMed ID: 19667109
[TBL] [Abstract][Full Text] [Related]
85. Allergic asthma aggravated atherosclerosis increases cholesterol biosynthesis and foam cell formation in apolipoprotein E-deficient mice.
Gao S; Wang C; Li W; Shu S; Zhou J; Yuan Z; Wang L
Biochem Biophys Res Commun; 2019 Nov; 519(4):861-867. PubMed ID: 31558320
[TBL] [Abstract][Full Text] [Related]
86. Moxibustion at CV4 alleviates atherosclerotic lesions through activation of the LXRα/ABCA1 pathway in apolipoprotein-E-deficient mice.
Cui Y; Liu J; Huang C; Zhao B
Acupunct Med; 2019 Aug; 37(4):237-243. PubMed ID: 31140825
[TBL] [Abstract][Full Text] [Related]
87. mRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease.
Soumian S; Gibbs R; Davies A; Albrecht C
J Clin Pathol; 2005 Dec; 58(12):1255-60. PubMed ID: 16311343
[TBL] [Abstract][Full Text] [Related]
88. Tofacitinib ameliorates atherosclerosis and reduces foam cell formation in apoE deficient mice.
Wang Z; Wang S; Wang Z; Yun T; Wang C; Wang H
Biochem Biophys Res Commun; 2017 Aug; 490(2):194-201. PubMed ID: 28601639
[TBL] [Abstract][Full Text] [Related]
89. PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infection.
Hanley TM; Blay Puryear W; Gummuluru S; Viglianti GA
PLoS Pathog; 2010 Jul; 6(7):e1000981. PubMed ID: 20617179
[TBL] [Abstract][Full Text] [Related]
90. PSRC1 overexpression attenuates atherosclerosis progression in apoE
Guo K; Hu L; Xi D; Zhao J; Liu J; Luo T; Ma Y; Lai W; Guo Z
J Mol Cell Cardiol; 2018 Mar; 116():69-80. PubMed ID: 29378206
[TBL] [Abstract][Full Text] [Related]
91. Arctigenin promotes cholesterol efflux from THP-1 macrophages through PPAR-γ/LXR-α signaling pathway.
Xu X; Li Q; Pang L; Huang G; Huang J; Shi M; Sun X; Wang Y
Biochem Biophys Res Commun; 2013 Nov; 441(2):321-6. PubMed ID: 24140409
[TBL] [Abstract][Full Text] [Related]
92. Visfatin induces cholesterol accumulation in macrophages through up-regulation of scavenger receptor-A and CD36.
Zhou F; Pan Y; Huang Z; Jia Y; Zhao X; Chen Y; Diao J; Wan Q; Cui X
Cell Stress Chaperones; 2013 Sep; 18(5):643-52. PubMed ID: 23494402
[TBL] [Abstract][Full Text] [Related]
93. Deficiency of adipose differentiation-related protein impairs foam cell formation and protects against atherosclerosis.
Paul A; Chang BH; Li L; Yechoor VK; Chan L
Circ Res; 2008 Jun; 102(12):1492-501. PubMed ID: 18483409
[TBL] [Abstract][Full Text] [Related]
94. Resveratrol Derivative, Trans-3, 5, 4'-Trimethoxystilbene, Prevents the Developing of Atherosclerotic Lesions and Attenuates Cholesterol Accumulation in Macrophage Foam Cells.
Hong M; Li J; Li S; Almutairi MM
Mol Nutr Food Res; 2020 Mar; 64(6):e1901115. PubMed ID: 31965713
[TBL] [Abstract][Full Text] [Related]
95. DNA topoisomerase II inhibitors induce macrophage ABCA1 expression and cholesterol efflux-an LXR-dependent mechanism.
Zhang L; Jiang M; Shui Y; Chen Y; Wang Q; Hu W; Ma X; Li X; Liu X; Cao X; Liu M; Duan Y; Han J
Biochim Biophys Acta; 2013 Jun; 1831(6):1134-45. PubMed ID: 23466610
[TBL] [Abstract][Full Text] [Related]
96. Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.
Mueller PA; Zhu L; Tavori H; Huynh K; Giunzioni I; Stafford JM; Linton MF; Fazio S
Circulation; 2018 Oct; 138(17):1850-1863. PubMed ID: 29794082
[TBL] [Abstract][Full Text] [Related]
97. Genetic and Pharmacologic Inhibition of the Neutrophil Elastase Inhibits Experimental Atherosclerosis.
Wen G; An W; Chen J; Maguire EM; Chen Q; Yang F; Pearce SWA; Kyriakides M; Zhang L; Ye S; Nourshargh S; Xiao Q
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29437605
[TBL] [Abstract][Full Text] [Related]
98. Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE
Shang Y; Ma C; Zhang J; Wang Z; Ren C; Luo X; Peng R; Liu J; Mao J; Shi Y; Fan G
Theranostics; 2020; 10(22):10231-10244. PubMed ID: 32929345
[No Abstract] [Full Text] [Related]
99. Peroxisome proliferator-activated receptor-gamma1 gene therapy attenuates atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice.
Hu Q; Zhang XJ; Zhang C; Zhao YX; He H; Liu CX; Feng JB; Jiang H; Yang FL; Zhang CX; Zhang Y
Hum Gene Ther; 2008 Mar; 19(3):287-299. PubMed ID: 18302511
[TBL] [Abstract][Full Text] [Related]
100. CXCL5 limits macrophage foam cell formation in atherosclerosis.
Rousselle A; Qadri F; Leukel L; Yilmaz R; Fontaine JF; Sihn G; Bader M; Ahluwalia A; Duchene J
J Clin Invest; 2013 Mar; 123(3):1343-7. PubMed ID: 23376791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
